
Opinion|Videos|February 17, 2025
Key Structural and Operational Considerations for Biosimilar Adoption
Panelists discuss how biosimilar adoption requires multifaceted organizational readiness, involving strategic infrastructure reconfiguration, comprehensive stakeholder education, rigorous clinical and economic evaluation frameworks, and adaptable operational processes to ensure seamless integration and optimization of health care delivery.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- When health care systems move to biosimilar adoption, what are the key structural and operational considerations that go into this transition?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Contributor: Engagement Is the Missing Link in Kidney Care—How Payers and Value-Based Partnerships Can Close the Gap
2
FDA Approves Selumetinib for Adults With Neurofibromatosis Type 1
3
Bronchiectasis Hospitalizations Deadlier, Costlier Than Those for COPD, Asthma
4
Reactivating CCNA2 Gene Enables Adult Heart Cells to Regenerate
5

















































